Novavax jumps after FDA asks for more data on its Covid vaccine [Yahoo! Finance]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance
to full approval despite US Health and Human Services Secretary Robert F. Kennedy Jr. raising doubts about its efficacy. Most Read from Bloomberg Trump Gives New York ‘One Last Chance' to End Congestion Fee DOGE Visits National Gallery of Art to Discuss Museum's Legal Status The Racial Wealth Gap Is Not Just About Money Backyard Micro-Flats Aim to Ease South Africa's Housing Crisis A Car Guy Makes a Left Turn The company said Wednesday the US Food and Drug Administration is seeking more clinical data as part of a “post marking commitment,” which are studies done on safety and efficacy after a product has been approved. The company's vaccine is already on the market under a conditional approval and it had expected to receive full approval on April 1. Sign in to Follow NVAX Investors saw the FDA's request as an encouraging sign. Novavax rose as much as 14% in pre-market trading. The full approval delay has been closely watched by vaccine makers as a potential sign of
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- Why I Wouldn't Touch Novavax With a 10-Foot Pole [Yahoo! Finance]Yahoo! Finance
- Novavax (NASDAQ:NVAX) had its "sell (d)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Novavax, Inc. (NVAX): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Pharma Stocks Fall After Leaked Memo Questions Vaccine Safety [Barron's]Barrons
- Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino [Yahoo! Finance Canada]Yahoo! Finance Canada
NVAX
Earnings
- 11/6/25 - Miss
NVAX
Sec Filings
- 11/12/25 - Form SCHEDULE
- 11/6/25 - Form 8-K
- 11/6/25 - Form 10-Q
- NVAX's page on the SEC website